T. Chitnis Et Al. , "Evaluation of teriflunomide in children and adolescents with relapsing MS: TERIKIDS phase 3 study design, enrolment update, and baseline data," 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) , vol.23, Paris, France, pp.109, 2017
Chitnis, T. Et Al. 2017. Evaluation of teriflunomide in children and adolescents with relapsing MS: TERIKIDS phase 3 study design, enrolment update, and baseline data. 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) , (Paris, France), 109.
Chitnis, T., Tardieu, M., Banwell, B., Gucuyener, K., Deiva, K., Achiron, A., ... Skripchenko, N.(2017). Evaluation of teriflunomide in children and adolescents with relapsing MS: TERIKIDS phase 3 study design, enrolment update, and baseline data . 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) (pp.109). Paris, France
Chitnis, T. Et Al. "Evaluation of teriflunomide in children and adolescents with relapsing MS: TERIKIDS phase 3 study design, enrolment update, and baseline data," 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), Paris, France, 2017
Chitnis, T. Et Al. "Evaluation of teriflunomide in children and adolescents with relapsing MS: TERIKIDS phase 3 study design, enrolment update, and baseline data." 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) , Paris, France, pp.109, 2017
Chitnis, T. Et Al. (2017) . "Evaluation of teriflunomide in children and adolescents with relapsing MS: TERIKIDS phase 3 study design, enrolment update, and baseline data." 7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) , Paris, France, p.109.
@conferencepaper{conferencepaper, author={T. Chitnis Et Al. }, title={Evaluation of teriflunomide in children and adolescents with relapsing MS: TERIKIDS phase 3 study design, enrolment update, and baseline data}, congress name={7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS)}, city={Paris}, country={France}, year={2017}, pages={109} }